For more than 30 years now, the Australasian Diabetes in Pregnancy Society (ADIPS) has led clinical guidance in relation to diabetes in pregnancy in Australia. ADIPS last updated consensus guidelines for the testing and diagnosis of GDM in 2014. The 2025 ADIPS Consensus Recommendations update guidance for the screening, diagnosis, and classification of hyperglycaemia in pregnancy based on extensive review of the evidence and consultation with multidisciplinary health professionals and consumer groups.

The full publication in the Medical Journal of Australia can be accessed here.

More information for you:

If you are pregnant, currently have GDM, or have had GDM in the past, we encourage you to read this article in The Conversation which summarises the changes and rationale for the new 2025 ADIPS Consensus Recommendations.  

We’ve also prepared some answers to frequently asked questions can be accessed here

More information for health professionals:

Health professionals are encouraged to read the full Consensus Recommendations published in the MJA.  We’ve also prepared some answers to frequently asked questions can be accessed here

For media: see the 23^rd June 2025 media release here

Endorsement and acceptance by peak bodies

The 2025 ADIPS Consensus Recommendations for the screening, diagnosis and classification of GDM have been endorsed or formally accepted by the following organisations:

Australian Association of Clinical Biochemists (AACB)

Australian College of Midwives (ACM)

Australian Diabetes Society (ADS)

Australian Diabetes Educators Association (ADEA)

Diabetes Australia (DA)

Endocrine Society of Australia (ESA)

Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG)

Royal College of Pathologists of Australasia (RCPA)

Royal Australian College of General Practitioners (RACGP)(Accepted Clinical Resource).

Society of Obstetric Medicine of Australia and New Zealand (SOMANZ)